Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Phase II Study With Light Dose Escalation During Intraoperative Photodynamic Therapy of Glioblastoma

NCT04391062 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04391062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04391062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Phase II Study With Light Dose Escalation During Intraoperative Photodynamic Therapy of Glioblastoma
Lead sponsor
University Hospital, Lille
Phase
Phase 2
Overall status
Completed
Start date
September 28, 2021
Completion date
March 25, 2024
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma